Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
40 hedge funds and large institutions have $53.9M invested in Vaxart in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.
2,100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 1
472% more capital invested
Capital invested by funds: $9.41M → $53.9M (+$44.5M)
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
100% more funds holding
Funds holding: 20 → 40 (+20)
13.19% less ownership
Funds ownership: 56.2% → 43% (-13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$778K |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$637K |
| 4 |
BlackRock
New York
|
+$608K |
| 5 |
QI
QS Investors
New York
|
+$481K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$63.4K |
| 2 |
PA
Parallel Advisors
San Francisco,
California
|
-$10.2K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
VXRT Hedge Fund Activity: Q1 2020 in Review
40 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2020, worth a combined $53.9M — up 472% from $9.41M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new VXRT positions and 1 closed out — a net gain of 21 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.02M. The largest seller was UBS Group, cutting an estimated $63.4K.
- 40 institutional investors held Vaxart (VXRT) as of Q1 2020, up from 20 in Q4 2019.
- Funds reported $53.9M of Vaxart stock for Q1 2020, up 472% quarter-over-quarter.
- 22 funds opened new Vaxart positions in Q1 2020 and 1 closed out, a net change of +21 holders.
- The largest Vaxart buyer in Q1 2020 was Renaissance Technologies, an estimated $1.02M added.
- The largest Vaxart seller in Q1 2020 was UBS Group, an estimated $63.4K sold.
Based on aggregated 13F filings for Q1 2020.